TITLE

Parenteral vitamin B12 therapy of hyperhomocysteinemia in end-stage renal disease

AUTHOR(S)
Hoffer, L. John; Elian, Kelly M.
PUB. DATE
February 2004
SOURCE
Clinical & Investigative Medicine;Feb2004, Vol. 27 Issue 1, p10
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: End-stage renal disease (ESRD) is associated with moderately severe hyperhomocysteinemia that is incompletely normalized by oral folic acid therapy and vitamin B12. Method: We administered 1 mg hydroxocobalamin parenterally at 14-day intervals to vitamin B12--replete hemo-dialysis patients who were already consuming 6 mg folic acid daily by mouth. Plasma total homocysteine (tHcy), serum folate, vitamin B12 and methylmalonate were measured immediately before and after 4 and 8 weeks of therapy. Results: Serum folate concentrations were consistently over 25 times the upper normal limit. Hydroxocobalamin therapy increased serum vitamin B12 concentrations 14-fold (p < 0.001) and reduced plasma tHcy by 23% from 29.7 ± 2.9 to 22.8 ± 2.5 µmol/L (p < 0.01); serum methylmalonate decreased by one-third (p < 0.05). Conclusions: These results demonstrate the Hcy-lowering potential of parenteral vitamin B12 in folic acid supple-mented vitamin B12--replete hemodialysis patients, and indicate the need for formal dose-optimization studies of this simple, inexpensive and promising approach to Hcy reduction in end-stage renal disease.
ACCESSION #
12485058

 

Related Articles

  • Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease. Stam, Frank; van Guldener, Coen; ter Wee, Piet M.; Jakobs, Cornelis; de Meer, Kees; Stehouwer, Coen D.A. // Kidney International;Jan2005, Vol. 67 Issue 1, p259 

    Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease.Background.The pathogenesis of hyperhomocysteinemia in end-stage renal disease (ESRD) is unclear. Folic acid lowers, but does not normalize, the plasma homocysteine level in patients with ESRD, but its...

  • Effect of Omega-3 Supplementation on Serum Level of Homocysteine in Hemodialysis Patients. Tayebi Khosroshahi, Hamid; Dehgan, Reza; Habibi Asl, Bahlul; Safaian, Abdolrasul; Panahi, Farid; Estakhri, Rasul; Purasgar, Behruz // Iranian Journal of Kidney Diseases;Nov2013, Vol. 7 Issue 6, p479 

    Introduction. Patients with end-stage renal disease are at a high risk of adverse cardiovascular events. Elevated level of homocysteine is an important risk factor for cardiovascular morbidity and mortality in dialysis patients. There are some strategies for reduction of serum homocysteine level...

  • Carnitine metabolism in patients with chronic renal failure: Effect of L-carnitine supplementation. Wanner, Christoph; Förstner-Wanner, Sabine; Rössle, Claudia; Fürst, Peter; Schollmeyer, Peter; Hörl, Walter H. // Kidney International Supplement;Oct1987, Issue 22, pS-132 

    Evaluates the effects of L-carnitine supplementation in patients undergoing regular hemodialysis. Examination of the carnitine metabolism in patients with chronic renal failure; Efficacy of continuous ambulatory peritoneal dialysis; Identification of chronic glomerulonephritis as the underlying...

  • Renal replacement therapy in Latin America. Fernandez-Cean, Juan; Gonzalez-Martinez, Francisco; Schwedt, Emma; Mazzuchi, Nelson // Kidney International Supplement;Jan2000, Issue 74, pS-55 

    Focuses on renal replacement therapy in Latin America. History of the Latin American Society of Nephrology and Hypertension Dialysis and Renal Transplantation Surgery; Prevalence of patients on dialysis; Variation of dialysis rate between countries.

  • Measuring the Quality of Dying. Moss, Alvin H. // Journal of Palliative Medicine;Jun2001, Vol. 4 Issue 2, p149 

    Editorial. Comments on a case report of a patient with end-stage renal disease who died after discontinuing dialysis. Attributes of a good death; Overview of the Dialysis Quality of Dying Adgar tool.

  • Vitaminas B y homocisteína en la insuficiencia renal crónica. Sánchez, C.; Planells, E.; Aranda, P.; Pérez De La Cruz, A.; Asensio, C.; Mataix, J.; Llopis, J. // Nutricion Hospitalaria;nov2007, Vol. 22 Issue 6, p661 

    Metabolic, biochemical, and hormonal changes occur in chronic renal failure usually associated with hyponutrition states. In predialysis patients, knowing the nutritional state about water-soluble vitamins such as thiamine, riboflavin, pyridoxine, cianocobalamine, and folic acid is becoming more...

  • Oral vitamin B[sub12] and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia. Manns, Braden; Hyndman, Eric; Burgess, Ellen; Parsons, Howard; Schaefer, Jeff; Snyder, Floyd; Scott-Douglas, Nairne // Kidney International;Mar2001, Vol. 59 Issue 3, p1103 

    Examines the effect of high-dose oral vitamin B[sub12] and folic acid on peridialysis total homocysteine levels in end-stage renal disease (ESRD) patients in Alberta, Canada. Decrease of screening homocysteine levels; Mean reduction of homocysteine levels after therapy; Investigation on risk of...

  • Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. Morton, Rachael L.; Snelling, Paul; Webster, Angela C.; Rose, John; Masterson, Rosemary; Johnson, David W.; Howard, Kirsten // CMAJ: Canadian Medical Association Journal;3/20/2012, Vol. 184 Issue 5, pE277 

    Background: For every patient with chronic kidney disease who undergoes renal-replacement therapy, there is one patient who undergoes conservative management of their disease. We aimed to determine the most important characteristics of dialysis and the trade-offs patients were willing to make in...

  • The renal benefits of a healthy lifestyle. de Francisco, Angél L.M.; Fresnedo, Gema Fernández; Palomar, Rosa; Piñera, Celestino; Arias, Manuel // Kidney International Supplement;Dec2005, Issue 99, pS2 

    Over the next decade, the number of patients with end-stage renal disease requiring treatment by dialysis may double, and even developed nations will have difficulty coping with this alarming increase. There is an urgent need to highlight the importance of modifiable risk factors as a basis for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics